7 Best Christmas Tree Stands in 2022

Image
Believe it or not, a Christmas tree won't stay upright on its own. Instead, you need a stable Christmas tree stand that can accommodate the type and size of tree you have. We researched dozens of the best Christmas tree stands to help you find the right one for your needs, whether you have a real tree, an artificial tree, a small tree, or a behemoth. The stands in our guide have a track record of durability, performance, and easy setup. We also outline the size and type of tree each stand is meant for. Check out our guide to the best Christmas tree skirts once you've chosen the right stand for your tree. The best Christmas tree stands in 2022 Best Christmas tree stand overall: Krinner Tree Genie Christmas Tree Stand, available at Amazon, $82.79 The German-engineered Krinner Tree Genie Christmas Tree Stand is easy to set up in a couple of minutes and keeps trees up to 12 f...

Italy’s Chiesi Farmaceutici to buy Amryt Pharma in a $1.48-billion deal


Italy’s Chiesi Farmaceutici said on Sunday it will acquire Ireland-based drugmaker Amryt Pharma Plc, which has products and drugs in development for treating rare diseases, in a deal valued at $1.48 billion.

The total value of the all-cash deal represents a 107 per cent premium over Dublin, Ireland-based Amryt’s ADS closing price of $7.00 on Jan. 6, the companies said in a joint announcement.

Amryt shareholders will receive $14.50 per ADS cash upfront, plus Contingent Value Rights (CVR) of up to an additional $2.50 per ADS based on achievement of certain milestones by Filsuvez, a drug approved in Europe for an inherited skin disease called epidermolysis bullosa.

“This addition of the Amryt portfolio, as well as their expertise, will help us on our journey to bring medicines to patients, no matter how rare their condition may be,” Chiesi Group Chief Executive Marco Vecchia said in a statement.

For first nine months of 2022, Amryt reported $188.8 million in revenue, and reaffirmed its full-year forecast for revenue of $260 million to $270 million. Its top-selling drug, Myalept or Myalepta, had third-quarter sales of $37.9 million.

https://www.tausiinsider.com/italys-chiesi-farmaceutici-to-buy-amryt-pharma-in-a-1-48-billion-deal/?feed_id=325750&_unique_id=63f9f5b2b7a53

Comments

Popular posts from this blog

An Existentialist Guide to Feeling Nothing

What Are SQL Stored Procedures and How Do You Create Them?

7 Best Christmas Tree Stands in 2022